MOESM1 of Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts

Additional file 1: Figure S1. Yield of cells during manufacturing process. Proportion of cell count on d-1, d0, and d9 of manufacturing process compared to cell count of starting material before cryopreservation of 5 independent manufacturing processes of material of mobilized donors.